Back
Immunovant Vs. Denali Therapeutics Industry Stock Comparison
Sell
50
IMVT
Immunovant
Last Price:
29.20
Seasonality Move:
78.38%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.94
Seasonality Move:
17.79%
Sell
50
Immunovant (IMVT)
is a Sell
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $29.61. The Score for IMVT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.08. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $29.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
IMVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 47.15 | Sell |
Chaikin Money Flow: | 137319 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.48 - 32.24) | Sell |
Bollinger Bands (100): | (26.83 - 30.87) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.89 | Buy |
Relative Strength Index (14 RSI): | 78.97 | Buy |
Chaikin Money Flow: | -360034 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.61 - 28.65) | Buy |
Bollinger Bands (100): | (19.18 - 25.48) | Buy |
IMVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.29 | Buy |
20-day SMA: | 30.77 | Sell |
50-day SMA: | 29.87 | Sell |
200-day SMA: | 32.44 | Sell |
8-day EMA: | 29.65 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 29.86 | Sell |
200-day EMA: | 29.83 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.38 | Buy |
20-day SMA: | 26.7 | Buy |
50-day SMA: | 24.56 | Buy |
200-day SMA: | 20.65 | Buy |
8-day EMA: | 29.49 | Buy |
20-day EMA: | 27.36 | Buy |
50-day EMA: | 25.05 | Buy |
200-day EMA: | 22.29 | Buy |
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.66 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Immunovant Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |